IE912999A1 - Phenanthridine compounds - Google Patents

Phenanthridine compounds

Info

Publication number
IE912999A1
IE912999A1 IE299991A IE299991A IE912999A1 IE 912999 A1 IE912999 A1 IE 912999A1 IE 299991 A IE299991 A IE 299991A IE 299991 A IE299991 A IE 299991A IE 912999 A1 IE912999 A1 IE 912999A1
Authority
IE
Ireland
Prior art keywords
phenanthridine
hydroxy
compounds
hydrogen
pharmaceutically acceptable
Prior art date
Application number
IE299991A
Other languages
English (en)
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of IE912999A1 publication Critical patent/IE912999A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/18—Ring systems of four or more rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IE299991A 1990-09-07 1991-08-23 Phenanthridine compounds IE912999A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57901890A 1990-09-07 1990-09-07

Publications (1)

Publication Number Publication Date
IE912999A1 true IE912999A1 (en) 1992-03-11

Family

ID=24315251

Family Applications (1)

Application Number Title Priority Date Filing Date
IE299991A IE912999A1 (en) 1990-09-07 1991-08-23 Phenanthridine compounds

Country Status (5)

Country Link
AU (1) AU8610991A (fr)
IE (1) IE912999A1 (fr)
IL (1) IL99310A0 (fr)
PT (1) PT98893A (fr)
WO (1) WO1992004356A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100292928B1 (ko) * 1992-05-26 2001-11-05 프란시스 제이 메이어 치환된헥사하이드로벤조페난트리딘
JPH10502923A (ja) * 1994-07-15 1998-03-17 パーデュー・リサーチ・ファンデーション ジヒドレキシジンおよびその置換類似体の光学活性異性体
US5659037A (en) * 1994-08-18 1997-08-19 Abbott Laboratories Process for preparing chiral tetracyclic dopaminergic compounds
ES2169257T3 (es) * 1995-08-18 2002-07-01 Purdue Research Foundation Nuevas isoquinolinas fusionadas como ligandos del receptor de la dopamina.
ES2314189T3 (es) * 2002-02-15 2009-03-16 Darpharma, Inc. Profarmacos monoester y diester asimetricamente sustituidos de los agonistas del receptor d1 de dopamina.
WO2010124005A1 (fr) 2009-04-21 2010-10-28 Purdue Research Foundation Modulateurs octahydrobenzoisoquinoléines de récepteurs de la dopamine, et utilisations de ces modulateurs
PL3106149T3 (pl) 2009-05-29 2020-06-01 Pearl Therapeutics, Inc. Kompozycje do płucnego dostarczania długo-działających antagonistów muskarynowych i długo-działających agonistów receptora beta-2 adrenergicznego oraz powiązane sposoby i układy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3939165A (en) * 1974-11-14 1976-02-17 Morton-Norwich Products, Inc. 5,6,6A,6B,7,8-Hexahydrobenz[a]phenanthridine hydrochloride
US4963568A (en) * 1989-05-31 1990-10-16 Abbott Laboratories Dopamine agonists

Also Published As

Publication number Publication date
IL99310A0 (en) 1992-07-15
AU8610991A (en) 1992-03-30
PT98893A (pt) 1992-07-31
WO1992004356A1 (fr) 1992-03-19

Similar Documents

Publication Publication Date Title
EP0474767B1 (fr) Agonistes de dopamine
KR100487032B1 (ko) 약제로서신규한브리지된시클릭아미노산
EP0363415B1 (fr) Composes permettant le traitement de la maladie d'alzheimer
SG183265A1 (en) Secondary structure stabilized nmda receptor modulators and uses thereof
US4994486A (en) Dopaminergic compounds
US4320148A (en) 2-Aminotetralin compounds, pharmaceutical compositions and method of producing central alpha1 agonist activity
IE912999A1 (en) Phenanthridine compounds
Schwab 14-(Arylhydroxyamino) codeinones and derivatives as analgetics and antagonists
JP2012526077A (ja) 新規イソキノリン誘導体
FI88162C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara sulfonyldekahydro-8h-isokino/2,1-g//1,6/naftyridiner, deras optiska isomerer samt farmaceutiskt godtagbara salter
US5668141A (en) Trans-2,6-,3,6-and 4,6-diaza-5,6,6a,7,8,12b-hexahydrobenzo[c]phenanthrene compounds as dopamine agonists
US5158948A (en) Tetracyclic spirobenzazepine dopamine antagonists
RU2300532C2 (ru) Производные бензо[g]хинолина для лечения глаукомы и близорукости, способ их получения и фармацевтическая композиция
US5641785A (en) Oxazoloquinolinone derivatives, their preparation and their therapeutic application as inhibitors of monoamine oxidase
WO2013038200A2 (fr) Troubles neurodéveloppementaux
EP0127143B1 (fr) Aryloxycycloalkanolaminoalkylène-aryl-cétones
NZ233002A (en) 3-(aminoalkyl)benzothiopyran derivatives and pharmaceutical compositions
EP1149079B1 (fr) Derives de tetrahydro isoquino linealcanol et compositions pharmaceutiques contenants ces derives
EP1282625B1 (fr) Benzoxazines pour le traitement de la maladie de parkinson
US5955471A (en) Tetrahydroisoquinolinealkanol derivatives and pharmaceutical compositions containing same
US6500837B2 (en) Fused ring system containing indole as M4 selective aza-anthracene muscarinic receptor antagonists
NZ556189A (en) New naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
EP0118566B1 (fr) DERIVES D'INDENO[1,2-b]PYRROLE
AU8224991A (en) Substituted naphthoxazines useful as dopaminergics
CA2035966A1 (fr) Composes